Aadi Bioscience Recalls

FDA
1
Total Recalls
1
Agencies
Nov 2022
First Recall
Nov 2022
Latest Recall
Sort: Newest first Highest severity

Showing 1-1 of 1 recalls

FDA

Fyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound), 100 mg per vial, NDC 80803-153-50, manufactured for Aadi Bioscience, Inc, CA.

Failed Stability Specifications